Synthaverse S.A. (SVE.WA) — Stock Score Summary

Synthaverse S.A. (SVE.WA) has a MoatMap StockRank of 10/100 based on Quality (24/100), Value (46/100), and Momentum (22/100) factor scores. The current signal is STRONG SELL. A Polish biotech/healthcare company that lacks the global scale, regulatory moat, and high-utilization capacity of the leading CDMOs targeted by our macro theme.

Synthaverse S.A. is a specialized biotechnology company that manufactures immunobiological drugs, including BCG vaccines and BCG-based oncology therapeutics for bladder cancer. The company is one of only a few global producers of BCG-derived products, benefiting from exceptionally high regulatory and technological barriers to entry. Synthaverse is currently expanding its production capacity to address chronic global shortages of these critical therapies.

Key Financial Metrics

Price$0.75
Market Cap$60M
Price/Book1.45
Return on Equity-16.2%
Return on Invested Capital-11.4%
Debt/Equity67.89
Gross Margin56.1%
Operating Margin-43.1%
Revenue Growth-40.1%
Free Cash Flow$-6M

Synthaverse S.A. operates in the Biotechnology industry, part of the Healthcare sector (Poland).

Frequently Asked Questions

What is Synthaverse S.A.’s (SVE.WA) StockRank?
MoatMap’s StockRank for Synthaverse S.A. (SVE.WA) is 10/100, with a Strong Sell signal. It is a composite of Quality (24), Value (46), and Momentum (22) factor ranks across MoatMap’s 19,000+ stock universe.
Does Synthaverse S.A. have an economic moat?
Synthaverse S.A. (SVE.WA) has a Quality factor score of 24/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Synthaverse S.A. a buy, hold, or sell?
MoatMap’s current signal for Synthaverse S.A. (SVE.WA) is Strong Sell, based on a StockRank of 10/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Synthaverse S.A. in?
Synthaverse S.A. (SVE.WA) operates in the Healthcare sector, specifically the Biotechnology industry (Poland).
Browse all ranked stocksSVE.WA deep dive reportAI ChampionsHow we score stocksSense-check another stock